Entera Bio's Convertible Note Round

Entera Bio raised a round of funding on July 24, 2016.

Entera Bio (NASDAQ: ENTX) is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug …

Articles about Entera Bio's Convertible Note Round: